Russotti Gregory 4
4 · Century Therapeutics, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) CTO Gregory Russotti Sells Shares
What Happened
- Gregory Russotti, Chief Technology and Manufacturing Officer at Century Therapeutics (IPSC), sold 479 shares on 2026-03-09 at $2.54 per share, totaling $1,215.
- The sale was not an open-market discretionary trade for investment purposes; it was an automatic sale to cover tax withholding related to vesting restricted stock units.
Key Details
- Transaction date and price: 2026-03-09 — 479 shares sold at $2.54 each.
- Total proceeds: $1,215.
- Shares owned after transaction: Not specified in the filing.
- Footnote: The sale was to satisfy tax withholding obligations on vested RSUs; the sale was automatic and not at the reporting person’s discretion (footnote F1).
- Filing timeliness: Report filed 2026-03-11, within two business days of the transaction (timely).
Context
- Sales to cover tax withholding for vested restricted stock units are routine administrative transactions and do not necessarily signal the insider’s view on the company’s prospects.
- The relatively small dollar amount ($1.2K) underscores the administrative nature of the transaction rather than a material disposition.
Insider Transaction Report
Form 4
Russotti Gregory
See Remarks
Transactions
- Sale
Common Stock
[F1]2026-03-09$2.54/sh−479$1,215→ 525,503 total
Holdings
- 92,773(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Signature
/s/ Douglas Carr, Attorney-in-Fact|2026-03-11